Supriya Lifescience Ltd
NSE:SUPRIYA
Supriya Lifescience Ltd
NSE:SUPRIYA
Price:
696.6
INR
4.67%
Market Closed
Market Cap:
₹56.1B
Relative Value
The Relative Value of one
SUPRIYA
stock under the Base Case scenario is
532.38
INR.
Compared to the current market price of 696.6 INR,
Supriya Lifescience Ltd
is
Overvalued by 24%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SUPRIYA
Relative Value
Base Case
532.38
INR
Overvaluation 24%
Multiples Across Competitors
SUPRIYA Competitors Multiples
Supriya Lifescience Ltd Competitors
Supriya Lifescience Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Supriya Lifescience Ltd
NSE:SUPRIYA
|
56.1B INR | 7.8 | 30.7 | 21.3 | 23.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
947.4B USD | 16 | 51.6 | 34.7 | 37.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564B USD | 6 | 21 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
290.3B USD | 4.5 | 15.2 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.6B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 5.2 | 15.9 | 11 | 12.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
145.7B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
